4.1 When awarding an order by NEW ALPHA, NEW ALPHA indicates whether (and, if so, which part thereof) the ordered product is to be used for commercial sale, clinical supply, validation, stability or other uses, as well as any order relating to the quantities of the product that are sold commercially, indicates the entity: in which the production of generic medicines is to take place and the area where these quantities are sold. The unit price of the product and the price per lot of a pipeline calculated by GENERICO for each unit or lot supplied by GENERICO are set out in Annex 4.1. The price of the product and a pipeline does not include the delivery of the product or pipeline to NEW ALPHA or any of its distributors. The risk of loss of a product is transferred to the FOB shipping unit (i.e. the GENERICO production site). 5.1 GENERICO makes every right of it to cooperate with NEW ALPHA and its licensees with a view to obtaining all regulatory approvals for the product and pipelines in each territory, subject to clause 2.2 (C). Without limiting the foregoing, GENERICO will endeavor to provide NEW ALPHA with assistance in data tracking and data analysis related to manufacturing issues that NEW ALPHA may reasonably request. All data and information relating to such media regarding the product or a pipeline are, if they relate exclusively to the product or a pipeline, the exclusive property of NEW ALPHA and may be used by NEW ALPHA free of charge for NEW ALPHA in the manner defined by NEW ALPHA. . . .